Beta Bionics, Inc. recalls iLet Bionic Pancreas
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.
- Products
-
- iLet Bionic Pancreas
- Company
- Beta Bionics, Inc.
- Where it was sold
-
US Nationwide distribution in the states of TX, PA, AL, MI, OH, FL, TN, GA.
States: Alabama, Florida, Georgia, Michigan, Ohio, Pennsylvania, Tennessee, Texas
- Units affected
- 1,080
- About this recall
- iLet Bionic Pancreas, REF: BB1001